Aims & Scope:Organogenesis is a peer-reviewed journal, available in print and online, that publishes significant advances on all aspects of organ development. The journal covers organogenesis in all multi-cellular organisms and also includes research into tissue engineering, artificial organs and organ substitutes.
The overriding criteria for publication in Organogenesis are originality, scientific merit and general interest. The audience of the journal consists primarily of researchers and advanced students of anatomy, developmental biology and tissue engineering.
The emphasis of the journal is on experimental papers (full-length and brief communications), but it will also publish reviews, hypotheses and commentaries. The Editors encourage the submission of addenda, which are essentially auto-commentaries on significant research recently published elsewhere with additional insights, new interpretations or speculations on a relevant topic. If you have interesting data or an original hypothesis about organ development or artificial organs, please send a pre-submission inquiry to the Editor-in-Chief. You will normally receive a reply within days. All manuscripts will be subjected to peer review, and accepted manuscripts will be posted to the electronic site of the journal immediately and will appear in print at the earliest opportunity thereafter.
Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.
*Please note that Organogenesis converted to a full Open Access journal from Volume 18 (2022). Archive content published between 1997-2021 is free to access. From 2022 the Print ISSN is not in active use as this journal is no longer published in print.
Journal metrics
Usage
116K annual downloads/views
Citation metrics
1.6 (2023) Impact Factor
2.5 (2023) 5 year IF
4.1 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.754 (2023) SNIP
0.457 (2023) SJR
Speed/acceptance
35 days avg. from submission to first
decision
17% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editors-in-Chief Alejandro Soto-Gutierrez - University of Pittsburgh, Pittsburgh, PA, US
Executive Advisory Editorial Board
Anthony Atala - Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA Barbara D. Boyan - Virginia Commonwealth University, Richmond, VA, USA Robert A. Fisher - Chief Medical Officer, SP Global Inc., Chantilly, VA, USA Maria Koulmanda - Beth Israel Deaconess Medical Centre and Harvard Medical School, Boston, MA, USA Robert S. Langer - Massachusetts Institute of Technology, Cambridge, MA, USA Toshio Miki - Nihon University School of Medicine, Tokyo, Japan David J. Mooney - Harvard University, Cambridge, MA, USA Stephen Strom - Karolinska Institutet and Hospital, Stockholm, SE Joseph Vacanti - M assachusetts General Hospital and Harvard Medical School, Boston, MA, USA William R. Wagner - University of Pittsburgh, Pittsburgh, PA, USA Martin L. Yarmush - Departments of Biomedical & Chemical Engineering,Rutgers University, Piscataway, NJ, US; Center For Engineering in Medicine, MGH/Harvard Medical School, Boston, MA, USA
Associate Editors
Pedro Baptista - Aragon Health Sciences Institute, Zaragoza, ES Edward Botchwey - Georgia Institute of Technology, Atlanta, GA, USA Gerald Brandacher - Johns Hopkins University School of Medicine, Baltimore, MD, USA Julie Campbell - University of Queensland, St. Lucia, Queensland, AU Jamie A. Davies - University of Edinburgh Medical School, Edinburgh, UK Thomas W. Gilbert - University of Pittsburgh, Columbia, MD, USA Marc R. Hammerman - Washington University School of Medicine, St. Louis, MO, USA Suwan N. Jayasinghe - University College London, London, UK Ali Khademhosseini - Harvard Medical School, Cambridge, MA, USA Harald C. Ott - Massachussetts General Hospital, Boston, MA, USA Jean-Pierre Saint-Jeannet - New York University, New York, NY, USA Shelly Sakiyama-Ebert - Washington University, St. Louis, MO, USA
Editorial Board
Guillermo Ameer - Northwestern University, Evanston, IL, USA François Berthiaume - Rutgers University, New Brunswick, NJ, USA Sangeeta N. Bhatia - Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA Mikhail V Blagosklonny - Roswell Park Cancer Institute, Buffalo, NY, USA André Brändli - Ludwig-Maximilians-Universität München, Munich, DE Elliot Chaikof - Harvard University, Boston, MA, USA Igor B. Dawid - National Institute of Child Health and Human Development, Bethesda, MD, USA Danielle Dhouailly - Institut Albert Bonniot, La Tronche, FR Andrew W. Duncan - University of Pittsburgh, Pittsburgh, PA, USA Gregory Erickson - UC San Diego, La Jolla, CA, USA Thomas Eschenhagen - University-Hospital Hamburg-Eppendorf, Hamburg, DE Vincent Fleury - Université Paris-Diderot, Paris, FR Roberto Gramignoli - K arolinska University Hospital, Stockholm, SE Ueli Grossniklaus - University of Zurich, Zurich, CH Jeff Hardin - University of Wisconsin, Madison, WI, USA Stefan Heller - Stanford University School of Medicine, Stanford, CA, USA Tina Jaskoll - University of Southern California, Los Angeles, CA, USA Elizabeth A. Jones - Warwick University, Coventry, UK Gunnar Kratz - Linköping University, Linköping, SE Shaun M. Kunisaki - University of Michigan, Ann Arbor, MI, USA Yoshimitsu Kuroyanagi - Kitasato University, Sagamihara, Kanagawa, JP Nicolas L'Heureux - Cytograft Tissue Engineering, Inc., San Francisco, CA, USA Eric Lagasse - University of Pittsburgh, Pittsburgh, PA, USA Nicole M. Le Douarin - Institut de Neurobiologie-Alfred Fessard, Gif-sur-Yvette, FR Robin Lovell-Badge - MRC National Institute for Medical Research, London, UK Paul Martin - University of Bristol, Bristol, England, UK Marc Mercola - The Burnham Institute, La Jolla, CA, USA Randall T. Moon - HHMI/University of Washington, Seattle, WA, USA Deepak Nagrat - Rice University, Houston, TX, USA Yaakov Nahmias - The Hebrew University of Jerusalem, Jerusalem, IL Joan E. Nichols - The University of Texas Medical Branch, Galveston, TX, USA Sanjay K. Nigam - UC San Diego, La Jolla, CA, USA Michael Oertel - University of Pittsburgh, Pittsburgh, PA, USA Teruo Okano - Tokyo Women's Medical University, Tokyo, JP M. Joana Osorio - C enter for Translational Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA Biju Parekkadan - Harvard Medical School, Boston, MA, USA Bryon E. Petersen - University of Florida, Gainesville, FL, USA Klaus Pfeffer - Technical University of Munich, Munich, DE Martin Post - University of Toronto, Toronto, Ontario, CA Lawrence Rosenberg - McGill University, Montréal, Quebec, CA Trinidad Serrano - Universitario de Zaragoza, Zaragoza, ES Ramille Shah - Northwestern University, Evanston, IL, USA James Sharpe - Center for Genomic Regulation, Barcelona, ES Maria Z. Siemionow - Cleveland Clinic, Cleveland, OH, USA Shay Soker - The Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA Charles Streuli - University of Manchester, Manchester, UK Irma Thesleff - University of Helsinki, Helsinki, FI Axel Thomson - Medical Research Council, Edinburgh, UK Arno Tilles - Harvard Medical School, Boston, MA, USA Jorma Toppari - University of Turku, Turku, FI Parsia A. Vagefi - Massachusetts General Hospital, Boston, MA, USA Aart van Apeldoorn - University of Twente, MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, NL Steven N. Vaslef - Duke University, Durham, NC, USA Gordana Vunjak-Novakovic - Columbia University, New York, NY, USA Valerie M. Weaver - University of California at San Francisco, San Francisco, CA Zhen Zhao - University of Southern California, Los Angeles, CA, USA Peter Zilla - University of Cape Town, Cape Town, ZA
Abstracting and indexing
Organogenesis is abstracted/indexed in:
Adis International Ltd. - Reactions Weekly (Online)
DOAJ
EBSCOhost - Biological Abstracts (Online) - Biomedical Reference Collection: Corporate Edition - TOC Premier (Table of Contents)
Elsevier BV - BIOBASE - EMBASE - Scopus
National Library of Medicine - PubMed/MEDLINE
Thomson Reuters - Biological Abstracts (Online) - BIOSIS Previews - Biotechnology Citation Index (Online) - Science Citation Index Expanded - Web of Science
Open access
Organogenesis is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![Gates Open Research is a platform for rapid author-led publication and open peer review of research funded by the Bill & Melinda Gates Foundation.]({"type":"image" , "src" : "/sda/112431/GATES-KB.jpg"})